Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received November 1, 2022
- Accepted September 25, 2023
- Published online October 25, 2023.
Article Versions
- previous version (October 17, 2023 - 05:56).
- You are currently viewing a previous version of this article (October 25, 2023 - 08:41).
- View the most recent version of this article
Copyright & Usage
Copyright © 2023, Parenteral Drug Association
Author Information
- Camellia Zamiri1,23 (zamiri.camellia{at}gene.com),
- Danielle L. Leiske2 (danielle.leiske{at}abcellera.com),
- Patricia F. Hughes3 (patricia.hughes{at}fda.hhs.gov),
- J. Paul Kirwan4 (jkirwan{at}amgen.com),
- Evelyn Der5 (eder{at}gene.com),
- Emily Cox6 (emily.cox1{at}astrazeneca.com),
- Rob Warburton7 (warburton_robert_e{at}lilly.com),
- Monica Goss8 (monicap{at}amgen.com),
- Sarah Weiser9 (sarah.weiser{at}pfizer.com),
- Janet Perez-Brown10 (janet.perezbrown{at}bms.com),
- Ganapathy Gopalrathnam11 (gopalrathnam_ganapathy{at}lilly.com),
- Jing Liu12 (jliu{at}seagen.com),
- Shyam B. Mehta13 (shyam.mehta02{at}tevapharm.com),
- Shebeer Shereefa14 (shebeer.shereefa{at}abbvie.com),
- Sebastian Specht15 (sebastian.specht{at}roche.com),
- Sandra J. Aedo16 (saedoalm{at}its.jnj.com),
- Pierre Goldbach17 (pierre.goldbach{at}roche.com),
- Feng Jia18 (feng.jia{at}biogen.com),
- Barbara Kuehnle19 (barbara.kuehnle{at}boehringer-ingelheim.com),
- Scott Page14 (scott.page{at}abbvie.com),
- Liesbeth Voeten20 (lvoeten{at}its.jnj.com),
- Li Yi21 (li.yi{at}abbvie.com) and
- Chen Zhu22 (chen.zhu2{at}sanofi.com)
- 1 Pharmaceutical Development, Genentech (A Member of the Roche group), 1 DNA Way, South San Francisco, CA 94080, USA;
- 2 Product Quality Management, Seagen, 21717 30th Drive S.E. Bothell, WA 98021, USA;
- 3 Office of Pharmaceutical Manufacturing Assessment, Office of Product Quality FDA/CDER, 10903 New Hampshire Ave., Silver Spring, MD 20993, USA;
- 4 Global Regulatory Affairs and Strategy, CMC, Amgen, One Amgen Center Dr, Thousand Oaks, CA 91320, USA;
- 5 PTQP Analytical Sciences Chapter, Genentech (A Member of the Roche group), 1 DNA Way, South San Francisco, CA 94080, USA;
- 6 BioPharmaceuticals Development, R&D, Dosage Form Design and Development, AstraZeneca, 1 Medimmune Way, Gaithersburg, MD, 20878, USA;
- 7 Bioproduct Research & Development, Eli Lilly & Company, Lilly Research Laboratories Eli Lilly and Company, Indianapolis, IN 46285, USA;
- 8 Drug Product Technologies, Amgen, One Amgen Center Dr, Thousand Oaks, CA 91320, USA;
- 9 BTx PharmSci, Pharmaceutical Research and Development, Pfizer; 1 Burtt Rd, Andover, MA 01810, USA;
- 10 Microbiology Center of Excellence, BMS, One Squibb Drive New Brunswick, NJ 08903, USA;
- 11 Bioproduct Pharma Design, Eli Lilly & Company, Lilly Research Laboratories, Eli Lilly and Company Indianapolis, IN 46285 USA;
- 12 Pharmaceutical Sciences, Seagen, 21717 30th Drive S.E. Bothell, WA 98021, USA;
- 13 Drug Product Development and Operations, CMC Biologics Teva Branded Pharmaceutical Products, 145 Brandywine Pkwy, West Chester, PA 19380 USA;
- 14 Regulatory Affairs CMC, AbbVie,1 N Waukegan Rd, North Chicago, IL 60064, USA;
- 15 Regulatory Affairs, CMC, Roche, F. Hoffmann-La Roche Ltd., Basel 4070, Switzerland;
- 16 BioTherapeutics Drug Product Development Janssen, Pharmaceutical Companies of Johnson & Johnson, Janssen Research and Development, Malvern, PA 19355, USA;
- 17 Pharmaceutical Development & Supplies, Pharma Technical Development, Roche, F. Hoffmann-La Roche Ltd., Basel 4070, Switzerland;
- 18 Biologics Drug Product, Biogen, 225 Binney Street, Cambridge, MA 02142, USA;
- 19 Pharmaceutical Development, BI, Boehringer Ingelheim Pharma GmbH & Co. KG;
- 20 Analytical Development, Microbiology Center of Excellence Janssen, Pharmaceutical Companies of Johnson & Johnson, Turnhoutseweg 30, 2340 Beerse, Belgium;
- 21 Formulation Development, AbbVie, 1000 Gateway Blvd, South San Francisco, CA 94080, USA;
- 22 Biologics Drug Product Development and Manufacturing, Sanofi, One the Mountain Road, Framingham, MA, 01701, USA
- ↵* Corresponding author; email: zamiri.camellia{at}gene.com